听菌知道 | 白色念珠菌：一览疾病危害与潜在新疗法

1. Crawford, A.C. et al. (2018) Biphasic zinc compartmentalisation in a human fungal pathogen. PLoS Pathog. 14, e1007013.

2. Łoboda,D.andRowinska-Zyrek,M. (2017) Zinc binding sites in Pra1,a zincophore from Candida albicans. DaltonTrans.46,13695–13703.

3. Citiulo, F. et al. (2012) Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog. 8, e1002777.

4. Crawford, A. and Wilson, D. (2015) Essential metals at the host–pathogen interface: nutritional immunity and micronutrient assimilation by human fungal pathogens. FEMS Yeast Res. 15, fov071.

5. Mayer, F.L. et al. (2013) Candida albicans pathogenicity mechanisms. Virulence 4, 119–128.

6. Brown, G.D. et al. (2012) Hidden killers: human fungal infections. Sci. Transl. Med. 4 (165), rv113.

7. Kullberg, B.J. and Arendrup, M.C. (2015) Invasive candidiasis. N. Engl. J. Med. 373, 1445–1456.

8. Zhu Y, Shi T, Lu X, et al. Fungal‐induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL‐22[J]. The EMBO journal, 2021, 40(11): e105320.

9. Li X V, Leonardi I, Putzel G G, et al. Immune regulation by fungal strain diversity in inflammatory bowel disease[J]. Nature, 2022, 603(7902): 672-678.

10. Alonso-Roman R, Last A, Mirhakkak M H, et al. Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity[J]. Nature Communications, 2022, 13(1): 1-15.

11. Zhong M, Xiong Y, Zhao J, et al. Candida albicans disorder is associated with gastric carcinogenesis[J]. Theranostics, 2021, 11(10): 4945.

12. Takagi J, Aoki K, Turner B S, et al. Mucin O-glycans are natural inhibitors of Candida albicans pathogenicity[J]. Nature Chemical Biology, 2022: 1-12.

13. MacAlpine J, Daniel-Ivad M, Liu Z, et al. A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase[J]. Nature communications, 2021, 12(1): 1-16.

原文链接：

笔记｜Duncan Wilson

编译｜wx

审校｜617

校对｜豫浮游生物